600993.SH
Mayinglong Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 24.01
−0.21%Next report
Analyst consensus
- Next report date
- Oct 30, 2026
- EPS estimate
- —
- Revenue estimate
- CNY 1.0B
Latest reported
- Last report date
- Aug 26, 2026
- EPS actual
- CNY 0.35
- EPS estimate
- —
- Revenue actual
- CNY 989.4M
- Revenue estimate
- CNY 999.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 26, 2026 | — | CNY 0.35 | — | CNY 989.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 30, 2026